Putative function of ADAM9, ADAM10, and ADAM17 as APP α-secretase

Biochemical and Biophysical Research Communications

Volumn 301, Issue 1, 2003, Pages 231-235

  Asai, Masashi ^a,b   Hattori, Chinatsu ^a   Szabó, Beáta ^a   Sasagawa, Noboru ^a   Maruyama, Kei ^c   Tanuma, Sei Ichi ^b   Ishiura, Shoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

A172 cells; ADAM10; ADAM17; ADAM9; Alzheimer's disease; APP; RNAi; Secretase

Indexed keywords

ADAM 10; ADAM 9; ALPHA SECRETASE; DOUBLE STRANDED RNA; METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CATALYSIS; CELL STRAIN; CELL STRAIN COS7; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION;

EID: 0037474447     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02999-6     Document Type: Article

References (33)

1. Alzheimer A. Ueber cine eigenartige Erkrankung der Hirnrinde. Zentralbl. Nervenheilk. Psychiatr. 30:1907;177-179.
2. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
3. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82:1995;4245-4249.
4. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
5. Sinha S., Anderson J.P., Barbour R., Basi G.S., Caccavello R., Davis D., Doan M., Dovey H.F., Frigon N., Hong J., Jacobson-Croak K., Jewett N., Keim P., Knops J., Lieberburg I., Power M., Tan H., Tatsuno G., Tung J., Schenk D., Seubert P., Suomensaari S.M., Wang S., Walker D., Zhao J., McConlogue L., John V. Purification and cloning of amyloid precursor protein. β -secretase from human brain Nature. 402:1999;537-540.
6. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., Citron M. β -Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science. 286:1999;735-741.
7. Yan R., Bienkowski M.J., Shuck M.E., Miao H., Tory M.C., Pauley A.M., Brashier J.R., Stratman N.C., Mathews W.R., Buhl A.E., Carter D.B., Tomasselli A.G., Parodi L.A., Heinrikson R.L., Gurney M.E. Membrane-anchored aspartyl protease with Alzheimer's disease. β -secretase activity Nature. 402:1999;533-537.
8. Luo Y., Bolon B., Kahn S., Bennett B.D., Babu-Khan S., Denis P., Fan W., Kha H., Zhang J., Gong Y., Martin L., Louis J.C., Yan Q., Richards W.G., Citron M., Vassar R. Mice deficient in BACE1, the Alzheimer's. β -secretase, have normal phenotype and abolished β -amyloid generation Nature Neurosci. 4:2001;231-232.
9. Selkoe D.J. The cell biology of. β -amyloid precursor protein and presenilin in Alzheimer's disease Trends Cell Biol. 8:1998;447-453.
10. Li Y.M., Xu M., Lai M.T., Huang Q., Castro J.L., DiMuzio-Mower J., Harrison T., Lellis C., Nadin A., Neduvelil J.G., Register R.B., Sardana M.K., Shearman M.S., Smith A.L., Shi X.P., Yin K.C., Shafer J.A., Gardell S.J. Photoactivated. γ -secretase inhibitors directed to the active site covalently label presenilin 1 Nature. 405:2000;689-694.
11. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., Song Y.Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L., Yu H., Yang D.S., Holmes E., Milman P., Liang Y., Zhang D.M., Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y., Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P., St George-Hyslop P. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and. β APP processing Nature. 407:2000;48-54.
12. Koike H., Tomioka S., Sorimachi H., Saido T.C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., Ishiura S. Membrane-anchored metalloprotease MDC9 has an α-secretase activity responsible for processing the amyloid precursor protein Biochem. J. 343:1999;371-375.
13. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., Fahrenholz F. Constitutive and regulated. α -secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease Proc. Natl. Acad. Sci. USA. 96:1999;3922-3927.
14. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., Black R.A. Evidence that tumor necrosis factor. α converting enzyme is involved in regulated α -secretase cleavage of the Alzheimer amyloid protein precursor J. Biol. Chem. 273:1998;27765-27767.
15. Primakoff P., Myles D.G. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16:2000;83-87.
16. Moss M.L., White J.M., Lambert M.H., Andrews R.C. TACE and other ADAM proteases as targets for drug discovery. Drug Discov. Today. 6:2001;417-426.
17. Loechel F., Gilpin B.J., Engvall E., Albrechtsen R., Wewer U.M. Human ADAM 12 (meltrin. α ) is an active metalloprotease J. Biol. Chem. 273:1998;16993-16997.
18. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-. α from cells Nature. 385:1997;729-733.
19. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.L., Warner J., Willard D., Becherer J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature. 385:1997;733-736.
20. Arribas J., Coodly L., Vollmer P., Kishimoto T.K., Rose-John S., Massague J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271:1996;11376-11382.
21. Crowe P.D., Walter B.N., Mohler K.M., Otten-Evans C., Black R.A., Ware C.F. A metalloprotease inhibitor blocks shedding of the 80-kDa TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1995;1205-1210.
22. Mullberg J., Durie F.H., Otten-Evans C., Alderson M.R., Rose-John S., Cosman D., Black R.A., Mohler K.M. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J. Immunol. 155:1995;5198-5205.
23. Bennett T.A., Lynam E.B., Sklar L.A., Rogelj S. Hydroxamate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes: functional consequences for neutrophil aggregation. J. Immunol. 156:1996;3093-3097.
24. Qi H., Rand M.D., Wu X., Sestan N., Wang W., Rakic P., Xu T., Artavanis-Tsakonas S. Processing of the notch ligand delta by the metalloprotease Kuzbanian. Science. 283:1999;91-94.
25. Rosendahl M.S., Ko S.C., Long D.L., Brewer M.T., Rosenzweig B., Hedl E., Anderson L., Pyle S.M., Moreland J., Meyers M.A., Kohno T., Lyons D., Lichenstein H.S. Identification and characterization of a pro-tumor necrosis factor-. α -processing enzyme from the ADAM family of zinc metalloproteases J. Biol. Chem. 272:1997;24588-24593.
26. Millichip M.I., Dallas D.J., Wu E., Dale S., McKie N. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem. Biophys. Res. Commun. 245:1998;594-598.
27. Hattori M., Osterfield M., Flanagan J.G. Regulated cleavage of a contact-mediated axon repellent. Science. 289:2000;1360-1365.
28. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Miyado K., Tamai Y., Kurisaki T., Sehara-Fujisawa A., Ohno S., Mekada E.A. metalloprotease-disintegrin, MDC9/meltrin-. γ /ADAM9 and PKC δ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor EMBO J. 17:1998;7260-7272.
29. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
30. Hartmann D., de Strooper B., Serneels L., Craessaerts K., Herreman A., Annaert W., Umans L., Lubke T., Illert A.L., von Figura K., Saftig P. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for. α -secretase activity in fibroblasts Human Mol. Genet. 11:2002;2615-2624.
31. Weskamp G., Kratzschmar J., Reid M.S., Blobel C.P. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J. Cell Biol. 32:1996;717-726.
32. Hotoda N., Koike H., Sasagawa N., Ishiura S. A secreted form of human ADAM9 has an. α -secretase activity for APP Biochem. Biophys. Res. Commun. 293:2002;800-805.
33. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.